Cardiotoxicity of antineoplastic agents: what is the present and future role for imaging?
about
Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic DrugsDoes diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA).Electrophysiological effects of anthracyclines in adult survivors of pediatric malignancy.The Use of Imaging in the Prediction and Assessment of Cancer Treatment Toxicity.Cardio-Oncology: mechanisms of cardiovascular toxicity.Chemotherapeutic-Induced Cardiovascular Dysfunction: Physiological Effects, Early Detection-The Role of Telomerase to Counteract Mitochondrial Defects and Oxidative Stress.
P2860
Cardiotoxicity of antineoplastic agents: what is the present and future role for imaging?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cardiotoxicity of antineoplastic agents: what is the present and future role for imaging?
@en
type
label
Cardiotoxicity of antineoplastic agents: what is the present and future role for imaging?
@en
prefLabel
Cardiotoxicity of antineoplastic agents: what is the present and future role for imaging?
@en
P2860
P1476
Cardiotoxicity of antineoplastic agents: what is the present and future role for imaging?
@en
P2093
Maurie Markman
Timothy M Markman
P2860
P2888
P356
10.1007/S11912-014-0396-Y
P577
2014-01-01T00:00:00Z
P6179
1042305267